Panel Discussion: Identifying Targets to Simultaneously Tackle Neuroinflammation & Neurodegeneration

Time: 11:15 am
day: Day Two


• Debating targets impacting both neuroinflammation and neurodegeneration: RIPKI, ferroptosis, TDP43

• Discussing strategy for targeting two pathological processes simultaneously

• Outlining opportunities to de-risk future clinical trials

• Debating the future of neuroinflammation modulators as combination therapies in light of recent Alzheimer’s Disease therapeutic approvals